SLN12140

· Linno Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SLN12140, covering 2025-04-25 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: SLN12140 in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China [Phase 2]